These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 4809456)

  • 1. Leukemoid reaction in BALB-c mice bearing transplanted tumors.
    Kodama T; Sendo F; Kobayashi H
    Cancer Res; 1974 Jan; 34(1):176-80. PubMed ID: 4809456
    [No Abstract]   [Full Text] [Related]  

  • 2. Leukemoid reaction induced by different transplantable tumors in three inbred mouse strains.
    Castillo R; Díaz JW; Veloso A; Gavilondo J
    Neoplasma; 1982; 29(1):73-9. PubMed ID: 7070557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leukemoid reaction in BALB/c mice bearing primary tumors induced by 3-methylcholanthrene.
    Kodama T; Kawamura T; Kobayashi H
    Cancer Res; 1978 Mar; 38(3):713-5. PubMed ID: 626975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host genetic factors influencing the occurrence of leukemoid reaction in BALB/cMk mice bearing transplanted tumors.
    Kodama T; Kawamura T; Kobayashi H
    Cancer Res; 1978 Dec; 38(12):4662-4. PubMed ID: 719644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukemoid reaction in balb-c mice bearing transplantable tumor.
    Sendo F; Kodama T; Kobayashi H
    Gan; 1973 Jun; 64(3):297-300. PubMed ID: 4730597
    [No Abstract]   [Full Text] [Related]  

  • 6. Murine mammary carcinoma 4T1 induces a leukemoid reaction with splenomegaly: association with tumor-derived growth factors.
    DuPre' SA; Hunter KW
    Exp Mol Pathol; 2007 Feb; 82(1):12-24. PubMed ID: 16919266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological resistance to pulmonary metastases in C3Hf-Bu mice bearing syngeneic fibrosarcoma of different sizes.
    Milas L; Hunter N; Mason K; Withers HR
    Cancer Res; 1974 Jan; 34(1):61-71. PubMed ID: 4809463
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunotherapeutic studies in mice with the methanol-extraction residue (mer) fraction of BCG: solid tumors.
    Yron I; Weiss DW; Robinson E; Cohen D; Adelberg MG; Mekori T; Haber M
    Natl Cancer Inst Monogr; 1973 Dec; 39():33-55. PubMed ID: 4362523
    [No Abstract]   [Full Text] [Related]  

  • 9. Marked granulocytosis in C57BL/6 mice bearing a transplanted BMT-11 fibrosarcoma.
    Ishikawa M; Hosokawa M; Oh-hara N; Niho Y; Kobayashi H
    J Natl Cancer Inst; 1987 Mar; 78(3):567-71. PubMed ID: 3469467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of high dose of estradiol on ICRC mouse bearing transplanted mammary tumours.
    Pai SR; Save PG
    Indian J Med Res; 1976 Dec; 64(12):1788-92. PubMed ID: 1024080
    [No Abstract]   [Full Text] [Related]  

  • 11. Tumor immunity in vivo: evidence that immune destruction of tumor leaves "bystander" cells intact.
    Weissman IL
    J Natl Cancer Inst; 1973 Aug; 51(2):443-8. PubMed ID: 4765368
    [No Abstract]   [Full Text] [Related]  

  • 12. Neuraminidase and concanavalin A in the experimental immunotherapy of cancer.
    Simmons RL; Rios A
    Johns Hopkins Med J Suppl; 1974; 3():75-84. PubMed ID: 4536589
    [No Abstract]   [Full Text] [Related]  

  • 13. [Homologous anti-tissue antibodies as a factor supressing the development of malignant tumors].
    Saraeva ZM; Tereshchenko IP; Klemparskaia NN; Shal'nova GA
    Biull Eksp Biol Med; 1977 Oct; 84(10):468-71. PubMed ID: 912060
    [No Abstract]   [Full Text] [Related]  

  • 14. Tumor-specific resistance in mice detected by inhibition of macrophage migration.
    Vaage J; Jones RD; Brown BW
    Cancer Res; 1972 Apr; 32(4):680-7. PubMed ID: 4552377
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of different cancer treatment methods on immunity to an antigenic transplantable murine fibrosarcoma (Meth A).
    Khafagy M; Wanebo HJ; Alfieri A; Hahn EW
    AJR Am J Roentgenol; 1977 Jun; 128(6):1027-9. PubMed ID: 414534
    [No Abstract]   [Full Text] [Related]  

  • 16. Specific desensitization of resistance against a syngeneic methylcholanthrene-induced sarcoma in C3Hf mice.
    Vaage J
    Cancer Res; 1972 Feb; 32(2):193-9. PubMed ID: 5058179
    [No Abstract]   [Full Text] [Related]  

  • 17. Immune status of autochthonous and adoptively protected mice toward spontaneous and chemically induced tumors.
    Basombrío MA; Prehn RT
    Cancer Res; 1972 Nov; 32(11):2545-50. PubMed ID: 5082598
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro activity of lymphocytes and serum of C3Hf-Bu mice during the growth of methylcholanthrene-induced tumor and its regression following local irradiation.
    Jurin M; Suit HD
    Cancer Res; 1974 Apr; 34(4):672-8. PubMed ID: 4814987
    [No Abstract]   [Full Text] [Related]  

  • 19. Mechanism of heightened tumor immunity induced by cryosurgery.
    Faraci RP; Bagley DH; Marrone JC; Ketcham AS; Beazley RM
    Am Surg; 1975 May; 41(5):309-11. PubMed ID: 1130764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative immunotherapeutic effect of concanavalin A and neuraminidase-treated cancer cells.
    Simmons RL; Rios A
    Transplant Proc; 1975 Jun; 7(2):247-51. PubMed ID: 1129845
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.